BNP Paribas Financial Markets
BGMD

BNP Paribas Financial Markets’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

BNP Paribas Financial Markets’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,577
Closed -$6.62K – 4454
2014
Q2 		$6.62K Buy
1,577
+1,474
+1,431% +$6.99K ﹤0.01% 2465
2014
Q1 		$503 Hold
103
– – ﹤0.01% 3047
2013
Q4 		$428 Buy
+103
New +$299 ﹤0.01% 3955

Other funds holding BGMD

FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets's BGMD Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q3 2014, closing a stake of 1,577 shares — an estimated $6.62K sold.

BNP Paribas Financial Markets first reported a position in BGMD in Q4 2013 and held it in 3 quarters. The position peaked at $6.62K in Q2 2014. 27 funds tracked by Wall St. Rank hold BGMD as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining BG MEDICINE INC COM STK NEW position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,577 BG MEDICINE INC COM STK NEW shares in Q3 2014, an estimated $6.62K.
  • BNP Paribas Financial Markets first reported a position in BG MEDICINE INC COM STK NEW in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's BG MEDICINE INC COM STK NEW position peaked at $6.62K in Q2 2014.
  • 27 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.